SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 6 )*
Presstek, Inc.
-----------------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------------------
(Title of Class of Securities)
741113104
-----------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
CUSIP No. 741113104 13G Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. Lawrence Howard
###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 1,356,564 (includes options to purchase 175,000 shares)
BENEFICIALLY --------------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH 43,762
REPORTING --------------------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH 1,356,564 (includes options to purchase 175,000 shares)
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
43,762
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,400,326 as of 12/31/95 (total of 1,225,326 shares plus 175,000 shares
issuable upon exercise of immediately exercisable options)
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
<PAGE>
SCHEDULE 13G
Item 1(a). Name of Issuer:
Presstek, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
8 Commercial Street
Hudson, N.H. 03051
Item 2(a). Name of Person Filing:
Dr. Lawrence Howard
Item 2(b). Address of Principal Business Office Or, If None,
Residence:
Howard Capital Partners, Inc.
660 Madison Avenue
New York, New York 10021
Item 2(c). Citizenship:
United States of America
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
741113 10 4
Item 3. If this statement is filed pursuant to Rules 13d- 1(b) or
13d-2(b), check whether the person filing is a:
(a)-(h): Not applicable.
Item 4. Ownership:
(a) Amount Beneficially Owned: 1,400,326 shares of common
stock as of December 31, 1995, including 1,159,064 shares
owned by Dr. Howard, 17,500 shares owned by Dr. Howard's
wife, 26,262 shares owned by Dr. Howard's wife as custodian
for Dr. Howard's children, 22,500 shares owned by Dr. Howard
as custodian for his children and 175,000 shares which may
be purchased by Dr. Howard pursuant to currently exercisable
options. All share amounts (including shares issuable upon
exercise of options) have been adjusted to reflect the
effect of (i) a 5-4 split of the Issuer's common stock
effected in the form of a dividend of one share of common
stock for each four shares of
Page 3 of 5 pages
<PAGE>
common stock held of record by holders of record of common
stock on August 19, 1994 and (ii) a 2-1 split of the
Issuer's common stock effected in the form of a dividend of
one share of common stock for each one share of common stock
held of record by holders of record of common stock on May
1, 1995.
(b) Reference is made to Items Nos. 5-9 and 11 of
the Cover Sheet. Calculation of percentage of
beneficial ownership is based on 14,764,400
shares of the Issuer's common stock
outstanding on December 31, 1995.
(c) Reference is made to Items Nos. 5-9 and 11 of
the Cover Sheet.
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6. Ownership of More Than Five Percent on Behalf of
Another Person:
Not applicable.
Item 7. Identification and Classification of the
Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company:
Not applicable.
Item 8. Identification and Classification of Members of
the Group:
Not applicable.
Item 9. Notice of Dissolution of Group:
Not applicable.
Item 10. Certification:
Not applicable.
Page 4 of 5 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Date: February 13, 1996 Signature: /s/ Dr. Lawrence Howard
------------------------
Name/Title: Dr. Lawrence Howard
Page 5 of 5 pages
